全文获取类型
收费全文 | 4476篇 |
免费 | 319篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 52篇 |
儿科学 | 124篇 |
妇产科学 | 118篇 |
基础医学 | 625篇 |
口腔科学 | 134篇 |
临床医学 | 452篇 |
内科学 | 910篇 |
皮肤病学 | 65篇 |
神经病学 | 467篇 |
特种医学 | 174篇 |
外科学 | 609篇 |
综合类 | 20篇 |
一般理论 | 4篇 |
预防医学 | 347篇 |
眼科学 | 51篇 |
药学 | 348篇 |
中国医学 | 5篇 |
肿瘤学 | 298篇 |
出版年
2023年 | 42篇 |
2021年 | 58篇 |
2020年 | 68篇 |
2019年 | 79篇 |
2018年 | 113篇 |
2017年 | 121篇 |
2016年 | 132篇 |
2015年 | 138篇 |
2014年 | 155篇 |
2013年 | 312篇 |
2012年 | 282篇 |
2011年 | 282篇 |
2010年 | 224篇 |
2009年 | 124篇 |
2008年 | 210篇 |
2007年 | 240篇 |
2006年 | 210篇 |
2005年 | 212篇 |
2004年 | 252篇 |
2003年 | 174篇 |
2002年 | 200篇 |
2001年 | 38篇 |
2000年 | 22篇 |
1999年 | 40篇 |
1998年 | 38篇 |
1997年 | 37篇 |
1996年 | 44篇 |
1995年 | 44篇 |
1994年 | 41篇 |
1993年 | 31篇 |
1992年 | 36篇 |
1991年 | 32篇 |
1990年 | 26篇 |
1989年 | 26篇 |
1988年 | 25篇 |
1986年 | 36篇 |
1985年 | 30篇 |
1984年 | 46篇 |
1983年 | 21篇 |
1982年 | 32篇 |
1981年 | 35篇 |
1980年 | 25篇 |
1979年 | 26篇 |
1978年 | 24篇 |
1977年 | 24篇 |
1975年 | 24篇 |
1974年 | 25篇 |
1955年 | 39篇 |
1954年 | 89篇 |
1949年 | 20篇 |
排序方式: 共有4803条查询结果,搜索用时 31 毫秒
1.
2.
3.
The activity of a rheumatic disease can be influenced by pregnancy and puerperium. Prospective studies have shown an improvement in joint involvement in rheumatoid arthritis in two thirds to three quarters of pregnancies. After birth, an exacerbation is common. In spondylarthropathies there is no relevant change in disease activity. The fetal outcome is not impaired in patients with rheumatoid arthritis and inflammatory spondylarthropathies. Every pregnancy in women with a rheumatic disease should be considered as high-risk, and such pregnancies require close collaboration between rheumatologists and obstetricians. 相似文献
4.
Ulla Bergfeldt Kristian Borg Kjell Kullander Per Julin 《Journal of rehabilitation medicine》2006,38(3):166-171
OBJECTIVE: Analysis of the effects of a comprehensive focal spasticity program in adult patients. DESIGN: Retrospective study of an out-patient cohort. PATIENTS: One hundred patients were enrolled in the study (54 men and 46 women, mean age 41 years (SD 14). Cerebral palsy and stroke were equally common (80% in total). The remaining patients had miscellaneous diagnoses, including traumatic brain injury. METHODS: On average 230 units (SD 101) of botulinum toxin A Botox was given for 227 principal therapy targets chosen by the patient or the caregiver. One patient could have several targets for therapy. Administration of botulinum toxin was combined with 260 additional therapeutic interventions, most of which were forms of physical therapy. The effects were assessed after 6 weeks and compared with baseline functional abilities 1-2 weeks prior to therapy. RESULTS: Improvement was observed for 211 (93%) therapy targets, no change in 15 (7%), and impairment in 1, corresponding to an overall improvement in 90 patients (90%), 9 unchanged (9%) and worsening in 1. Spasticity assessment (Ashworth scale 0-4; 30 patients) showed a statistically significant improvement (median at baseline was 3 vs 2 after therapy, mean difference 1.2, p<0.001). CONCLUSION: Improvement was observed in >or=90% of patients and in their principal therapeutic targets in a cohort receiving their first focal spasticity treatment with botulinum toxin A and additional therapy. A strict strategy for patient selection and comprehensive management was followed. 相似文献
5.
Tori Smedal Hildegunn Lygren Kjell‐Morten Myhr Rolf Moe‐Nilssen Bente Gjelsvik Olav Gjelsvik Liv Inger Strand 《Physiotherapy research international》2006,11(2):104-116
Background and Purpose . Patients with multiple sclerosis (MS) tend to have movement difficulties, and the effect of physiotherapy for this group of patients has been subjected to limited systematic research. In the present study physiotherapy based on the Bobath concept, applied to MS patients with balance and gait problems, was evaluated. The ability of different functional tests to demonstrate change was evaluated. Method . A single‐subject experimental study design with ABAA phases was used, and two patients with relapsing–remitting MS in stable phase were treated. Tests were performed 12 times, three at each phase: A (at baseline); B (during treatment); A (immediately after treatment); and A (after two months). The key feature of treatment was facilitation of postural activity and selective control of movement. Several performance and self‐report measures and interviews were used. Results . After intervention, improved balance was shown by the Berg Balance Scale (BBS) in both patients, and improved quality of gait was indicated by the Rivermead Visual Gait Assessment (RVGA). The patients also reported improved balance and gait function in the interviews and scored their condition as ‘much improved’. Gait parameters, recorded by an electronic walkway, changed, but differently in the two patients. Among the physical performance tests the BBS and the RVGA demonstrated the highest change, while no or minimal change was demonstrated by the Rivermead Mobility Index (RMI) and Ratings of Perceived Exertion (RPE). Conclusion . The findings indicate that balance and gait can be improved after physiotherapy based on the Bobath concept, but this should be further evaluated in larger controlled trials of patients with MS. Copyright © 2006 John Wiley & Sons, Ltd. 相似文献
6.
Birgitta Malmberg Göran Kecklund Björn Karlson Roger Persson Per Flisberg Palle Ørbaek 《BMC health services research》2010,10(1):239
Background
It is well known that physicians' night-call duty may cause impaired performance and adverse effects on subjective health, but there is limited knowledge about effects on sleep duration and recovery time. In recent years occupational stress and impaired well-being among anaesthesiologists have been frequently reported for in the scientific literature. Given their main focus on handling patients with life-threatening conditions, when on call, one might expect sleep and recovery to be negatively affected by work, especially in this specialist group. The aim of the present study was to examine whether a 16-hour night-call schedule allowed for sufficient recovery in anaesthesiologists compared with other physician specialists handling less life-threatening conditions, when on call. 相似文献7.
8.
Possible genetic defects in regulation of glycosaminoglycans in patients with diabetic nephropathy 总被引:1,自引:0,他引:1
T Deckert I M Horowitz A Kofoed-Enevoldsen L Kjellén M Deckert C Lykkelund F Burcharth 《Diabetes》1991,40(6):764-770
The hypothesis of genetic defects in glycosaminoglycan (GAG) regulation among patients with insulin-dependent diabetes mellitus (IDDM) and nephropathy was assessed by studies in tissue cultures of fibroblasts obtained from 7 patients with normal urinary albumin excretion, 11 patients with diabetic nephropathy, and 6 nondiabetic control subjects. The incorporation of [2H] glucosamine and [35S] sulfate into hyaluronic acid (HA), chondroitin sulfate and dermatan sulfate (CS + DS), and heparan sulfate (HS) was measured in cells, matrix, and medium and related to micrograms of tissue protein. Large interindividual variations were seen in all three groups, and the incorporation of [3H] glucosamine into HA, CS + DS, and HS and [35S] sulfate into CS + DS and HS were not significantly different between the three groups. However, the fractional incorporation of [3H]glucosamine into HS was significantly reduced in diabetic patients with nephropathy compared with control subjects. This was the case not only when related to the total amount of GAGs (P = 0.014) but also when related to HA (P = 0.014). No significant difference was seen between control subjects and normoalbuminuric diabetic patients. The degree of N-sulfation of HS was not significantly different between the experimental groups. The results suggest that patients with diabetic nephropathy may suffer from deficiencies of coordinate regulation in the biosynthesis of GAG in fibroblasts, which may lead to a reduced density of HS in the extracellular matrix. If these changes reflect alterations in the biosynthesis of GAG from endothelial, myomedial, and mesangial cells, this observation may be relevant for the pathogenesis of severe diabetic complications. 相似文献
9.
10.
Heparin or heparan sulfate--what is the difference? 总被引:3,自引:0,他引:3